Inozyme gets $67mm via Series A2

15:40 EDT 15 Apr 2019 | Elsevier Business Intelligence

Inozyme Pharma Inc. (developing therapies for rare diseases of calcification) raised $67mm in its Series A2 financing led by ...

Original Article: Inozyme gets $67mm via Series A2


More From BioPortfolio on "Inozyme gets $67mm via Series A2"

Quick Search


Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...